Search Results

Nearly 100% of cancer patients with solid tumours have antibodies effective against the Delta variant after a third dose of COVID-19 vaccine, according to new results published as a correspondence in Cancer Cell this week.

Researchers at the Francis Crick Institute have shown in lab-based experiments that variants of SARS-CoV-2, the virus that causes COVID-19, can affect the blood-brain barrier and damage brain cells in different ways. This work gives clues as to how the virus could enter the brain, but doesn’t take into account the protection that people have acquired through vaccination.

Researchers at the Crick have identified structural changes in COVID-19 variants which provide clues to how the virus evolved to have greater levels of infectivity.

UK Prime Minister Boris Johnson received his second dose of COVID-19 vaccine today at the NHS vaccination centre at the Francis Crick Institute.

UCLH and the Francis Crick Institute have formed a partnership to deliver a new large-scale COVID-19 vaccination centre at the institute.

Researchers at the Crick and University of Dundee have screened thousands of drug and chemical molecules and identified a range of potential antivirals that could be developed into new treatments for COVID-19 or in preparation for future coronavirus outbreaks.

Researchers at the Crick, King’s College London and Guy's and St Thomas' NHS Foundation Trust have conducted a highly detailed analysis of the composition of immune cells in the blood of patients with COVID-19, revealing new aspects of how SARS-Cov-2 causes disease.

Patients receiving in-hospital dialysis treatment for kidney disease produce a larger neutralising antibody response when given the Pfizer-BioNTech COVID-19 vaccine, compared to the Oxford-AstraZeneca vaccine, according to laboratory findings published in The Lancet.

A third dose of the COVID-19 vaccine could increase protection from COVID-19 for people with cancer, and especially blood cancer, according to a new study from the Crick and The Royal Marsden NHS Foundation Trust 

Researchers at the Francis Crick Institute and King’s College London are joining forces with the Indian Institute of Science to explore how variations in the body’s initial immune defence and risk of cardiovascular disease affect COVID-19 outcomes for South Asian people living in the UK and in India.